Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia

Acta Oncol. 2017 Aug;56(8):1120-1121. doi: 10.1080/0284186X.2017.1287947. Epub 2017 Feb 17.

Affiliations

¹ a Hematology Unit , S. Eugenio Hospital , Rome , Italy.
² b Pathology Unit , S. Eugenio Hospital , Rome , Italy.
³ c Neuro Oncohematology Unit , Santa Lucia Foundation , Rome , Italy.
⁴ d Clinical Pathology , Regina Elena National Cancer Institute , Rome , Italy.

PMID: 28406054
DOI: 10.1080/0284186X.2017.1287947

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antimetabolites, Antineoplastic / therapeutic use*
Chemotherapy, Adjuvant
Decitabine / therapeutic use*
Humans
Induction Chemotherapy
Leukemia, Myeloid, Acute / drug therapy*
Maintenance Chemotherapy
Male
Neoadjuvant Therapy
Remission Induction
Salvage Therapy / methods*
Treatment Failure

Substances

Antimetabolites, Antineoplastic
Decitabine